Advances in diagnostic technology are reshaping infectious disease testing, and the Rabies Diagnostics Market is benefiting from this transition. Rabies diagnostic products are used by specialized laboratories, healthcare institutions, veterinary organizations, and public health agencies. Traditional testing remains important, but modern molecular platforms are gaining attention because they can support sensitive and efficient diagnostic workflows.

The market's development is also connected with digital healthcare and One Health surveillance. Combining information from human, animal, and environmental monitoring systems can help authorities identify disease patterns and improve response planning. Point-of-care diagnostics and smartphone-linked technologies could further improve reporting and surveillance in remote locations. According to Market Research Future, the market is projected to grow at a CAGR of 5.34% through 2035.

FAQ: What is One Health surveillance?
It is an integrated approach that considers human, animal, and environmental health when monitoring diseases such as rabies.

FAQ: Can digital technology support rabies diagnostics?
Digital platforms can support sample tracking, result reporting, surveillance databases, and communication between laboratories and public health authorities.